Vaccines Market - Top Companies and Manufacturers

  • Report ID: 1399
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Companies Dominating the Vaccines Landscape

    • GlaxoSmithKline plc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • Sanofi Aventis
    • Merck & Co., Inc.
    • Mitsubishi Tanabe Pharma Corporation
    • Bavarian Nordic A/S
    • Novartis AG
    • Inovio Pharmaceuticals, Inc.
    • CSL Limited
    • Emergence BioSolutions, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Pfizer Inc. to reveal the positive results from the Phase 3 study that has been recently conducted. The data from the study defines the 20-valent pneumococcal conjugate vaccine candidate. Apart from accomplishing positive results, the vaccine is still on its way to acquiring approval from requisite agencies.
  • GlaxoSmithKline plc to acquire prequalification from the World Health Organization (WHO) Mosquirix, additionally known as RTS, S/AS01. With this accomplishment, Mosquirix becomes the only approved vaccine for malaria. Furthermore, the vaccine I ready to be rolled out in the countries with a higher prevalence of P. falciparum malaria transmission.

Author Credits:  Radhika Pawar


  • Report ID: 1399
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of vaccines is assessed at USD 86.81 billion.

The vaccines market size was over USD 82.96 billion in 2024 and is anticipated to reach USD 171.11 billion by the end of 2037, growing at around 5.9% CAGR during the forecast period i.e., between 2025-2037. Growing demand for vaccines to cure hepatitis b and increasing cases of tuberculosis across the globe will boost the market growth.

Asia Pacific industry is likely to hold largest revenue share by 2037, owing to increment in birth rate, rising geriatric population and growing penetration of major key players in the region.

The major players in the market include Pfizer Inc., Sanofi Aventis, Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Bavarian Nordic A/S, Novartis AG, Inovio Pharmaceuticals, Inc., CSL Limited, and others. .
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample